MedTrace Logo

NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction

NCT03264859 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-08-29

No results posted yet for this study

Summary

The aim of this study is to investigate the association between NGAL plasma levels in ST-elevation myocardial infarction and the no-reflow phenomenon, adverse events during hospitalization and at 30-day follow-up.

Conditions

  • No-Reflow Phenomenon
  • STEMI - ST Elevation Myocardial Infarction

Interventions

DIAGNOSTIC_TEST

NGAL levels early and post STEMI

NGAL levels early and post ST elevation MI (STEMI)

Sponsors & Collaborators

  • Zotal Inc.

    collaborator UNKNOWN

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Shlomi Matetzky, Prof. · Sheba Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03264859 on ClinicalTrials.gov